AtlasOther conditionsOther non-communicable diseases

Endocrine, metabolic, blood, and immune disorders

3Curable in someAI-generated

Burden-over-time charts — how many people this disease affects and whether that number is rising or falling — are coming to this page. The treatability read, milestones, and live trial pipeline below are current.

Milestones

dot size = significance

1989: Drug approval — Epoetin alfa approved (FDA). 1989: Drug approval — Ganciclovir approved (FDA). 1989: Drug approval — Tolrestat approved (FDA). 1990: Drug approval — Idarubicin approved (FDA). 1990: Drug approval — Fluticasone propionate approved (FDA). 1990: Drug approval — Ebastine approved (FDA). 1991: Drug approval — Simvastatin approved (FDA). 1991: Drug approval — Fludarabine phosphate approved (FDA). 1991: Drug approval — Azithromycin approved (FDA). 1991: Drug approval — Ramipril approved (FDA). 1991: Drug approval — Etodolac approved (FDA). 1991: Drug approval — Felodipine approved (FDA). 1991: Drug approval — Didanosine approved (FDA). 1991: Drug approval — Nabumetone approved (FDA). 1991: Drug approval — Quinapril approved (FDA). 1991: Drug approval — Benazepril approved (FDA). 1991: Drug approval — Sargramostim approved (FDA). 1991: Drug approval — Pentostatin approved (FDA). 1991: Drug approval — Pravastatin approved (FDA). 1991: Drug approval — Foscarnet approved (FDA). 1991: Drug approval — Filgrastim approved (FDA). 1992: Drug approval — Oxaprozin approved (FDA). 1992: Drug approval — Rifabutin approved (FDA). 1992: Drug approval — Nedocromil approved (FDA). 1992: Drug approval — Amlodipine approved (FDA). 1993: Drug approval — Fluvastatin approved (FDA). 1993: Drug approval — Cladribine approved (FDA). 1993: Drug approval — Riboflavin approved (FDA). 1993: Drug approval — Fenofibrate approved (FDA). 1993: Drug approval — Interferon beta-1b approved (FDA). 1993: Drug approval — Loratadine approved (FDA). 1993: Drug approval — Felbamate approved (FDA). 1994: Drug approval — Famciclovir approved (FDA). 1994: Drug approval — Imiglucerase approved (FDA). 1994: Drug approval — Cysteamine approved (FDA). 1994: Drug approval — Asparaginase approved (FDA). 1994: Drug approval — Pegaspargase approved (FDA). 1994: Drug approval — Acrivastine approved (FDA). 1994: Drug approval — Tacrolimus anhydrous approved (FDA). 1994: Drug approval — Pheniramine approved (FDA). 1994: Drug approval — Voglibose approved (FDA). 1994: Drug approval — Budesonide approved (FDA). 1994: Drug approval — Stavudine approved (FDA). 1994: Drug approval — Salmeterol approved (FDA). 1995: Drug approval — Acarbose approved (FDA). 1995: Drug approval — Cetirizine approved (FDA). 1995: Drug approval — Saquinavir approved (FDA). 1995: Drug approval — Alendronic acid approved (FDA). 1995: Drug approval — Lamivudine approved (FDA). 1995: Drug approval — Glimepiride approved (FDA). 1995: Drug approval — Riluzole approved (FDA). 1995: Drug approval — Metformin approved (FDA). 1996: Drug approval — Phenylbutanoic acid approved (FDA). 1996: Drug approval — Ritonavir approved (FDA). 1996: Drug approval — Eptacog alfa (activated) approved (FDA). 1996: Drug approval — Atorvastatin approved (FDA). 1996: Drug approval — Interferon beta-1a approved (FDA). 1996: Drug approval — Insulin lispro approved (FDA). 1996: Drug approval — Betaine approved (FDA). 1996: Drug approval — Glatiramer acetate approved (FDA). 1996: Drug approval — Valsartan approved (FDA). 1996: Drug approval — Cidofovir anhydrous approved (FDA). 1996: Drug approval — Olopatadine approved (FDA). 1996: Drug approval — Azelastine approved (FDA). 1996: Drug approval — Ibandronic acid approved (FDA). 1996: Drug approval — Nevirapine approved (FDA). 1996: Drug approval — Fexofenadine approved (FDA). 1996: Drug approval — Miglitol approved (FDA). 1996: Drug approval — Zileuton approved (FDA). 1996: Drug approval — Zafirlukast approved (FDA). 1996: Drug approval — Indinavir anhydrous approved (FDA). 1997: Drug approval — Daclizumab approved (FDA). 1997: Drug approval — Oprelvekin approved (FDA). 1997: Drug approval — Anagrelide approved (FDA). 1997: Drug approval — Coagulation factor ix recombinant human approved (FDA). 1997: Drug approval — Rituximab approved (FDA). 1997: Drug approval — Troglitazone approved (FDA). 1997: Drug approval — Irbesartan approved (FDA). 1997: Drug approval — Repaglinide approved (FDA). 1997: Drug approval — Emedastine approved (FDA). 1997: Drug approval — Sibutramine approved (FDA). 1997: Drug approval — Raloxifene approved (FDA). 1997: Drug approval — Epoetin beta approved (FDA). 1997: Drug approval — Lepirudin approved (FDA). 1997: Drug approval — Nelfinavir approved (FDA). 1998: Drug approval — Glucagon approved (FDA). 1998: Drug approval — Montelukast approved (FDA). 1998: Drug approval — Abacavir approved (FDA). 1998: Drug approval — Efavirenz approved (FDA). 1998: Drug approval — Loteprednol etabonate approved (FDA). 1998: Drug approval — Candesartan cilexetil approved (FDA). 1998: Drug approval — Telmisartan approved (FDA). 1998: Drug approval — Sevelamer hydrochloride approved (FDA). 1998: Drug approval — Risedronic acid approved (FDA). 1998: Drug approval — Orlistat approved (FDA). 1998: Drug approval — Infliximab approved (FDA). 1998: Drug approval — Etanercept approved (FDA). 1998: Drug approval — Basiliximab approved (FDA). 1998: Drug approval — Mizolastine approved (FDA). 1998: Drug approval — Celecoxib approved (FDA). 1998: Drug approval — Leflunomide approved (FDA). 1999: Drug approval — Insulin aspart approved (FDA). 1999: Drug approval — Rosiglitazone approved (FDA). 1999: Drug approval — Cholecalciferol approved (FDA). 1999: Drug approval — Pioglitazone approved (FDA). 1999: Drug approval — Moroctocog alfa approved (FDA). 1999: Drug approval — Bexarotene approved (FDA). 1999: Drug approval — Fomivirsen approved (FDA). 1999: Drug approval — Deferiprone approved (FDA). 1999: Drug approval — Ketotifen approved (FDA). 1999: Drug approval — Interferon gamma-1b approved (FDA). 1999: Drug approval — Denileukin diftitox approved (FDA). 1999: Drug approval — Amprenavir approved (FDA). 2000: Drug approval — Iron sucrose approved (FDA). 2000: Drug approval — Meloxicam approved (FDA). 2000: Drug approval — Argatroban approved (FDA). 2000: Drug approval — Bivalirudin approved (FDA). 2000: Drug approval — Arsenic trioxide approved (FDA). 2000: Drug approval — Nateglinide approved (FDA). 2000: Drug approval — Colesevelam approved (FDA). 2000: Drug approval — Calcium carbonate approved (FDA). 2000: Drug approval — Isopropyl alcohol approved (FDA). 2000: Drug approval — Octocog alfa approved (FDA). 2000: Drug approval — Lopinavir approved (FDA). 2000: Drug approval — Choriogonadotropin alfa approved (FDA). 2000: Drug approval — Insulin glargine approved (FDA). 2000: Drug approval — Gemtuzumab ozogamicin approved (FDA). 2001: Drug approval — Tenofovir disoproxil approved (FDA). 2001: Drug approval — Coagulation factor ix human approved (FDA). 2001: Drug approval — Agalsidase alfa approved (FDA). 2001: Drug approval — Agalsidase beta approved (FDA). 2001: Drug approval — Imatinib approved (FDA). 2001: Drug approval — Esomeprazole approved (FDA). 2001: Drug approval — Alemtuzumab approved (FDA). 2001: Drug approval — Formoterol approved (FDA). 2001: Drug approval — Darbepoetin alfa approved (FDA). 2001: Drug approval — Anakinra approved (FDA). 2001: Drug approval — Rasburicase approved (FDA). 2001: Drug approval — Desloratadine approved (FDA). 2001: Drug approval — Pimecrolimus approved (FDA). 2001: Drug approval — Valganciclovir approved (FDA). 2001: Drug approval — Zoledronic acid anhydrous approved (FDA). 2001: Drug approval — Protein c concentrate (human) approved (FDA). 2001: Drug approval — Valdecoxib approved (FDA). 2002: Drug approval — Adalimumab approved (FDA). 2002: Drug approval — Yttrium y 90 ibritumomab tiuxetan approved (FDA). 2002: Drug approval — Insulin human zinc approved (FDA). 2002: Drug approval — Insulin human, isophane approved (FDA). 2002: Drug approval — Pegfilgrastim approved (FDA). 2002: Drug approval — Miglustat approved (FDA). 2002: Drug approval — Epoetin delta approved (FDA). 2002: Drug approval — Nitisinone approved (FDA). 2002: Drug approval — Olmesartan medoxomil approved (FDA). 2002: Drug approval — Ezetimibe approved (FDA). 2002: Drug approval — Teriparatide approved (FDA). 2003: Drug approval — Epinastine approved (FDA). 2003: Drug approval — Atazanavir approved (FDA). 2003: Drug approval — Emtricitabine approved (FDA). 2003: Drug approval — Enfuvirtide approved (FDA). 2003: Drug approval — Rosuvastatin approved (FDA). 2003: Drug approval — Laronidase approved (FDA). 2003: Drug approval — Fosamprenavir approved (FDA). 2003: Drug approval — Carglumic acid approved (FDA). 2003: Drug approval — Omalizumab approved (FDA). 2003: Drug approval — Alefacept approved (FDA). 2004: Drug approval — Tiotropium approved (FDA). 2004: Drug approval — Duloxetine approved (FDA). 2004: Drug approval — Insulin detemir approved (FDA). 2004: Drug approval — Natalizumab approved (FDA). 2004: Drug approval — Insulin glulisine approved (FDA). 2004: Drug approval — Mycophenolic acid approved (FDA). 2004: Drug approval — Clofarabine approved (FDA). 2004: Drug approval — Ranelic acid approved (FDA). 2004: Drug approval — Rifaximin approved (FDA). 2004: Drug approval — Omega-3-acid ethyl esters approved (FDA). 2004: Drug approval — Cinacalcet approved (FDA). 2004: Drug approval — Azacitidine approved (FDA). 2004: Drug approval — Glutamine approved (FDA). 2005: Drug approval — Tipranavir approved (FDA). 2005: Drug approval — Pramlintide approved (FDA). 2005: Drug approval — Galsulfase approved (FDA). 2005: Drug approval — Exenatide approved (FDA). 2005: Drug approval — Tocilizumab approved (FDA). 2005: Drug approval — Posaconazole approved (FDA). 2005: Drug approval — Deferasirox approved (FDA). 2005: Drug approval — Lenalidomide approved (FDA). 2005: Drug approval — Nelarabine approved (FDA). 2006: Drug approval — Rimonabant approved (FDA). 2006: Drug approval — Antithrombin alfa approved (FDA). 2006: Drug approval — Zinc oxide approved (FDA). 2006: Drug approval — Abatacept approved (FDA). 2006: Drug approval — Dasatinib anhydrous approved (FDA). 2006: Drug approval — Human immunoglobulin g approved (FDA). 2006: Drug approval — Sitagliptin approved (FDA). 2006: Drug approval — Ciclesonide approved (FDA). 2006: Drug approval — Vorinostat approved (FDA). 2006: Drug approval — Parathyroid hormone approved (FDA). 2006: Drug approval — Lactic acid approved (FDA). 2006: Drug approval — Decitabine approved (FDA). 2006: Drug approval — Darunavir approved (FDA). 2006: Drug approval — Sodium ascorbate approved (FDA). 2006: Drug approval — Idursulfase approved (FDA). 2006: Drug approval — Alglucosidase alfa approved (FDA). 2007: Drug approval — Sevelamer approved (FDA). 2007: Drug approval — Insulin, neutral approved (FDA). 2007: Drug approval — Raltegravir approved (FDA). 2007: Drug approval — Epoetin zeta approved (FDA). 2007: Drug approval — Temsirolimus approved (FDA). 2007: Drug approval — Methoxy polyethylene glycol-epoetin beta approved (FDA). 2007: Drug approval — Fluticasone furoate approved (FDA). 2007: Drug approval — Sapropterin approved (FDA). 2007: Drug approval — Maraviroc approved (FDA). 2007: Drug approval — Levocetirizine approved (FDA). 2007: Drug approval — Vildagliptin approved (FDA). 2007: Drug approval — Eculizumab approved (FDA). 2007: Drug approval — Nilotinib approved (FDA). 2008: Drug approval — Icatibant approved (FDA). 2008: Drug approval — Eltrombopag approved (FDA). 2008: Drug approval — Fenofibric acid approved (FDA). 2008: Drug approval — Plerixafor approved (FDA). 2008: Drug approval — Febuxostat approved (FDA). 2008: Drug approval — Certolizumab pegol approved (FDA). 2008: Drug approval — Romiplostim approved (FDA). 2008: Drug approval — Etravirine approved (FDA). 2008: Drug approval — Bendamustine approved (FDA). 2008: Drug approval — Menthol approved (FDA). 2008: Drug approval — Levoleucovorin approved (FDA). 2008: Drug approval — Rilonacept approved (FDA). 2009: Drug approval — Ferumoxytol approved (FDA). 2009: Drug approval — Bepotastine approved (FDA). 2009: Drug approval — Ecallantide approved (FDA). 2009: Drug approval — Golimumab approved (FDA). 2009: Drug approval — Lasofoxifene approved (FDA). 2009: Drug approval — Pitavastatin approved (FDA). 2009: Drug approval — Tocofersolan approved (FDA). 2009: Drug approval — Romidepsin approved (FDA). 2009: Drug approval — Pralatrexate approved (FDA). 2009: Drug approval — Bazedoxifene approved (FDA). 2009: Drug approval — Ustekinumab approved (FDA). 2009: Drug approval — Epoetin theta approved (FDA). 2009: Drug approval — Saxagliptin anhydrous approved (FDA). 2009: Drug approval — Tolvaptan approved (FDA). 2009: Drug approval — Ofatumumab approved (FDA). 2009: Drug approval — Carfilzomib approved (FDA). 2009: Drug approval — Liraglutide approved (FDA). 2009: Drug approval — Canakinumab approved (FDA). 2009: Drug approval — Amifampridine approved (FDA). 2010: Drug approval — Pegloticase approved (FDA). 2010: Drug approval — Levomefolic acid approved (FDA). 2010: Drug approval — Conestat alfa approved (FDA). 2010: Drug approval — Denosumab approved (FDA). 2010: Drug approval — Velaglucerase alfa approved (FDA). 2010: Drug approval — Fingolimod approved (FDA). 2010: Drug approval — Tesamorelin approved (FDA). 2010: Drug approval — Dalfampridine approved (FDA). 2010: Drug approval — Alcaftadine approved (FDA). 2010: Drug approval — Ticagrelor approved (FDA). 2011: Drug approval — Ruxolitinib approved (FDA). 2011: Drug approval — Pirfenidone approved (FDA). 2011: Drug approval — Linagliptin approved (FDA). 2011: Drug approval — Human c1-esterase inhibitor approved (FDA). 2011: Drug approval — Belimumab approved (FDA). 2011: Drug approval — Belatacept approved (FDA). 2011: Drug approval — Rilpivirine approved (FDA). 2011: Drug approval — Canagliflozin anhydrous approved (FDA). 2011: Drug approval — Asparaginase erwinia chrysanthemi approved (FDA). 2011: Drug approval — Brentuximab vedotin approved (FDA). 2011: Drug approval — Tafamidis approved (FDA). 2011: Drug approval — Methylene blue cation approved (FDA). 2012: Drug approval — Teduglutide approved (FDA). 2012: Drug approval — Teriflunomide approved (FDA). 2012: Drug approval — Lomitapide approved (FDA). 2012: Drug approval — Alipogene tiparvovec approved (FDA). 2012: Drug approval — Pixantrone approved (FDA). 2012: Drug approval — Elvitegravir approved (FDA). 2012: Drug approval — Ponatinib approved (FDA). 2012: Drug approval — Icosapent ethyl approved (FDA). 2012: Drug approval — Lorcaserin approved (FDA). 2012: Drug approval — Cobicistat approved (FDA). 2012: Drug approval — Catridecacog approved (FDA). 2012: Drug approval — Tofacitinib approved (FDA). 2012: Drug approval — Dapagliflozin approved (FDA). 2012: Drug approval — Taliglucerase alfa approved (FDA). 2012: Drug approval — Bosutinib approved (FDA). 2013: Drug approval — Vilanterol approved (FDA). 2013: Drug approval — Pomalidomide approved (FDA). 2013: Drug approval — Dimethyl fumarate approved (FDA). 2013: Drug approval — Ferric carboxymaltose approved (FDA). 2013: Drug approval — Insulin degludec approved (FDA). 2013: Drug approval — Lixisenatide approved (FDA). 2013: Drug approval — Ipragliflozin approved (FDA). 2013: Drug approval — Alogliptin approved (FDA). 2013: Drug approval — Human coagulation factor viii approved (FDA). 2013: Drug approval — Turoctocog alfa approved (FDA). 2013: Drug approval — Von willebrand factor human approved (FDA). 2013: Drug approval — Mipomersen approved (FDA). 2013: Drug approval — Obinutuzumab approved (FDA). 2013: Drug approval — Ibrutinib approved (FDA). 2013: Drug approval — Cholic acid approved (FDA). 2013: Drug approval — Neostigmine approved (FDA). 2013: Drug approval — Lipegfilgrastim approved (FDA). 2013: Drug approval — Dolutegravir approved (FDA). 2013: Drug approval — Colestilan chloride approved (FDA). 2013: Drug approval — Glycerol phenylbutyrate approved (FDA). 2014: Drug approval — Afamelanotide approved (FDA). 2014: Drug approval — Dulaglutide approved (FDA). 2014: Drug approval — Elosulfase alfa approved (FDA). 2014: Drug approval — Belinostat approved (FDA). 2014: Drug approval — Idelalisib approved (FDA). 2014: Drug approval — Ferric citrate anhydrous approved (FDA). 2014: Drug approval — Metreleptin approved (FDA). 2014: Drug approval — Peginterferon beta-1a approved (FDA). 2014: Drug approval — Simoctocog alfa approved (FDA). 2014: Drug approval — Albiglutide approved (FDA). 2014: Drug approval — Empagliflozin approved (FDA). 2014: Drug approval — Blinatumomab approved (FDA). 2014: Drug approval — Eliglustat approved (FDA). 2014: Drug approval — Siltuximab approved (FDA). 2014: Drug approval — Apremilast approved (FDA). 2014: Drug approval — Pembrolizumab approved (FDA). 2015: Drug approval — Secukinumab approved (FDA). 2015: Drug approval — Mepolizumab approved (FDA). 2015: Drug approval — Asfotase alfa approved (FDA). 2015: Drug approval — Daratumumab approved (FDA). 2015: Drug approval — Idebenone approved (FDA). 2015: Drug approval — Ixazomib citrate approved (FDA). 2015: Drug approval — Panobinostat approved (FDA). 2015: Drug approval — Tenofovir alafenamide approved (FDA). 2015: Drug approval — Patiromer sorbitex calcium approved (FDA). 2015: Drug approval — Lesinurad approved (FDA). 2015: Drug approval — Evolocumab approved (FDA). 2015: Drug approval — Nivolumab approved (FDA). 2015: Drug approval — Alirocumab approved (FDA). 2015: Drug approval — Evogliptin approved (FDA). 2015: Drug approval — Susoctocog alfa approved (FDA). 2015: Drug approval — Sebelipase alfa approved (FDA). 2015: Drug approval — Patiromer calcium approved (FDA). 2015: Drug approval — Elotuzumab approved (FDA). 2015: Drug approval — Efmoroctocog alfa approved (FDA). 2016: Drug approval — Albutrepenonacog alfa approved (FDA). 2016: Drug approval — Crisaborole approved (FDA). 2016: Drug approval — Autologous cd34+ enriched cell fraction that contains cd34+ cells transduced with retroviral vector that encodes for the human ada cdna sequence approved (FDA). 2016: Drug approval — Venetoclax approved (FDA). 2016: Drug approval — Ferric maltol approved (FDA). 2016: Drug approval — Migalastat approved (FDA). 2016: Drug approval — Allogeneic t cells genetically modified with a retroviral vector encoding for a truncated form of the human low affinity nerve growth factor receptor (deltalngfr) and the herpes simplex i virus thymidine kinase (hsv-tk mut2) approved (FDA). 2016: Drug approval — Ephedrine approved (FDA). 2016: Drug approval — Reslizumab approved (FDA). 2016: Drug approval — Coagulation factor x human approved (FDA). 2016: Drug approval — Eftrenonacog alfa approved (FDA). 2016: Drug approval — Ixekizumab approved (FDA). 2017: Drug approval — Nonacog beta pegol approved (FDA). 2017: Drug approval — Lonoctocog alfa approved (FDA). 2017: Drug approval — Copanlisib approved (FDA). 2017: Drug approval — Emicizumab approved (FDA). 2017: Drug approval — Abaloparatide approved (FDA). 2017: Drug approval — Sarilumab approved (FDA). 2017: Drug approval — Guselkumab approved (FDA). 2017: Drug approval — Vestronidase alfa approved (FDA). 2017: Drug approval — Edaravone approved (FDA). 2017: Drug approval — Baricitinib approved (FDA). 2017: Drug approval — Midostaurin approved (FDA). 2017: Drug approval — Ocrelizumab approved (FDA). 2017: Drug approval — Brodalumab approved (FDA). 2017: Drug approval — Calcium gluconate approved (FDA). 2017: Drug approval — Benralizumab approved (FDA). 2017: Drug approval — Dupilumab approved (FDA). 2017: Drug approval — Ertugliflozin approved (FDA). 2017: Drug approval — Enasidenib approved (FDA). 2017: Drug approval — Semaglutide approved (FDA). 2017: Drug approval — Inotuzumab ozogamicin approved (FDA). 2017: Drug approval — Cerliponase alfa approved (FDA). 2017: Drug approval — Acalabrutinib approved (FDA). 2018: Drug approval — Gilteritinib approved (FDA). 2018: Drug approval — Velmanase alfa approved (FDA). 2018: Drug approval — Tagraxofusp approved (FDA). 2018: Drug approval — Lorlatinib approved (FDA). 2018: Drug approval — Duvelisib approved (FDA). 2018: Drug approval — Moxetumomab pasudotox approved (FDA). 2018: Drug approval — Burosumab approved (FDA). 2018: Drug approval — Sodium zirconium cyclosilicate approved (FDA). 2018: Drug approval — Mogamulizumab approved (FDA). 2018: Drug approval — Damoctocog alfa pegol approved (FDA). 2018: Drug approval — Antihemophilic factor, pegylated (mw 20000) human sequence recombinant approved (FDA). 2018: Drug approval — Ravulizumab approved (FDA). 2018: Drug approval — Pegvaliase approved (FDA). 2018: Drug approval — Caplacizumab approved (FDA). 2018: Drug approval — Avatrombopag approved (FDA). 2018: Drug approval — Lusutrombopag approved (FDA). 2018: Drug approval — Fostamatinib approved (FDA). 2018: Drug approval — Vonicog alfa approved (FDA). 2018: Drug approval — Tisagenlecleucel approved (FDA). 2018: Drug approval — Ivosidenib approved (FDA). 2018: Drug approval — Glasdegib approved (FDA). 2018: Drug approval — Ibalizumab approved (FDA). 2018: Drug approval — Doravirine approved (FDA). 2018: Drug approval — Bictegravir approved (FDA). 2018: Drug approval — Elapegademase approved (FDA). 2018: Drug approval — Patisiran sodium approved (FDA). 2018: Drug approval — Emapalumab approved (FDA). 2018: Drug approval — Darvadstrocel approved (FDA). 2018: Drug approval — Lanadelumab approved (FDA). 2018: Drug approval — Tildrakizumab approved (FDA). 2018: Drug approval — Calaspargase pegol approved (FDA). 2018: Drug approval — Axicabtagene ciloleucel approved (FDA). 2019: Drug approval — Fedratinib approved (FDA). 2019: Drug approval — Risankizumab approved (FDA). 2019: Drug approval — Crizanlizumab approved (FDA). 2019: Drug approval — Diroximel fumarate approved (FDA). 2019: Drug approval — Upadacitinib approved (FDA). 2019: Drug approval — Siponimod approved (FDA). 2019: Drug approval — Givosiran sodium approved (FDA). 2019: Drug approval — Ropeginterferon alfa-2b approved (FDA). 2019: Drug approval — Selinexor approved (FDA). 2019: Drug approval — Romosozumab approved (FDA). 2019: Drug approval — Betibeglogene autotemcel approved (FDA). 2019: Drug approval — Sotagliflozin approved (FDA). 2019: Drug approval — Turoctocog alfa pegol approved (FDA). 2019: Drug approval — Polatuzumab vedotin approved (FDA). 2019: Drug approval — Voxelotor approved (FDA). 2019: Drug approval — Zanubrutinib approved (FDA). 2019: Drug approval — Luspatercept approved (FDA). 2020: Drug approval — Brexucabtagene autoleucel approved (FDA). 2020: Drug approval — Imlifidase approved (FDA). 2020: Drug approval — Belantamab mafodotin approved (FDA). 2020: Drug approval — Inebilizumab approved (FDA). 2020: Drug approval — Setmelanotide approved (FDA). 2020: Drug approval — Berotralstat approved (FDA). 2020: Drug approval — Lonafarnib approved (FDA). 2020: Drug approval — Bempedoic acid approved (FDA). 2020: Drug approval — Cedazuridine approved (FDA). 2020: Drug approval — Inclisiran sodium approved (FDA). 2020: Drug approval — Isatuximab approved (FDA). 2020: Drug approval — Monomethyl fumarate approved (FDA). 2020: Drug approval — Ozanimod approved (FDA). 2020: Drug approval — Tazemetostat approved (FDA). 2020: Drug approval — Fostemsavir approved (FDA). 2020: Drug approval — Teprotumumab approved (FDA). 2020: Drug approval — Satralizumab approved (FDA). 2020: Drug approval — Filgotinib approved (FDA). 2020: Drug approval — Tafasitamab approved (FDA). 2020: Drug approval — Atidarsagene autotemcel approved (FDA). 2020: Drug approval — Defatted powder of arachis hypogaea l., semen (peanuts) approved (FDA). 2020: Drug approval — Ferric derisomaltose approved (FDA). 2021: Drug approval — Dasiglucagon hydrochloride approved (FDA). 2021: Drug approval — Anifrolumab approved (FDA). 2021: Drug approval — Loncastuximab tesirine approved (FDA). 2021: Drug approval — Voclosporin approved (FDA). 2021: Drug approval — Idecabtagene vicleucel approved (FDA). 2021: Drug approval — Roxadustat approved (FDA). 2021: Drug approval — Avacopan approved (FDA). 2021: Drug approval — Asciminib approved (FDA). 2021: Drug approval — Fosdenopterin approved (FDA). 2021: Drug approval — Cabotegravir approved (FDA). 2021: Drug approval — Melphalan flufenamide approved (FDA). 2021: Drug approval — Abrocitinib approved (FDA). 2021: Drug approval — Belumosudil approved (FDA). 2021: Drug approval — Avalglucosidase alfa approved (FDA). 2021: Drug approval — Umbralisib approved (FDA). 2021: Drug approval — Pegcetacoplan approved (FDA). 2021: Drug approval — Finerenone approved (FDA). 2021: Drug approval — Bimekizumab approved (FDA). 2021: Drug approval — Ponesimod approved (FDA). 2021: Drug approval — Evinacumab approved (FDA). 2021: Drug approval — Elivaldogene autotemcel approved (FDA). 2021: Drug approval — Efgartigimod alfa approved (FDA). 2021: Drug approval — Tezepelumab approved (FDA). 2021: Drug approval — Tralokinumab approved (FDA). 2022: Drug approval — Ublituximab approved (FDA). 2022: Drug approval — Tirzepatide approved (FDA). 2022: Drug approval — Olipudase alfa approved (FDA). 2022: Drug approval — Olutasidenib approved (FDA). 2022: Drug approval — Eptacog beta (activated) approved (FDA). 2022: Drug approval — Eflapegrastim approved (FDA). 2022: Drug approval — Sutimlimab approved (FDA). 2022: Drug approval — Mitapivat approved (FDA). 2022: Drug approval — Mosunetuzumab approved (FDA). 2022: Drug approval — Lenacapavir approved (FDA). 2022: Drug approval — Ciltacabtagene autoleucel approved (FDA). 2022: Drug approval — Teclistamab approved (FDA). 2022: Drug approval — Tabelecleucel approved (FDA). 2022: Drug approval — Eladocagene exuparvovec approved (FDA). 2022: Drug approval — Spesolimab approved (FDA). 2022: Drug approval — Teplizumab approved (FDA). 2022: Drug approval — Vutrisiran approved (FDA). 2022: Drug approval — Vutrisiran sodium approved (FDA). 2022: Drug approval — Pacritinib approved (FDA). 2022: Drug approval — Valoctocogene roxaparvovec approved (FDA). 2023: Drug approval — Zilucoplan sodium approved (FDA). 2023: Drug approval — Exagamglogene autotemcel approved (FDA). 2023: Drug approval — Iptacopan approved (FDA). 2023: Drug approval — Efanesoctocog alfa approved (FDA). 2023: Drug approval — Sparsentan approved (FDA). 2023: Drug approval — Crisantaspase approved (FDA). 2023: Drug approval — Epcoritamab approved (FDA). 2023: Drug approval — Elranatamab approved (FDA). 2023: Drug approval — Apadamtase alfa approved (FDA). 2023: Drug approval — Glofitamab approved (FDA). 2023: Drug approval — Talquetamab approved (FDA). 2023: Drug approval — Tofersen approved (FDA). 2023: Drug approval — Omidubicel approved (FDA). 2023: Drug approval — Omidubicel non-cultured fraction approved (FDA). 2023: Drug approval — Coagulation factor vii human approved (FDA). 2023: Drug approval — Protein s human approved (FDA). 2023: Drug approval — Leniolisib approved (FDA). 2023: Drug approval — Mirikizumab approved (FDA). 2023: Drug approval — Daprodustat approved (FDA). 2023: Drug approval — Pegzilarginase approved (FDA). 2023: Drug approval — Vadadustat approved (FDA). 2023: Drug approval — Omaveloxolone approved (FDA). 2023: Drug approval — Motixafortide acetate approved (FDA). 2023: Drug approval — Pirtobrutinib approved (FDA). 2023: Drug approval — Momelotinib approved (FDA). 2023: Drug approval — Lovotibeglogene autotemcel approved (FDA). 2023: Drug approval — Efbemalenograstim alfa approved (FDA). 2023: Drug approval — Bexagliflozin approved (FDA). 2023: Drug approval — Eplontersen sodium approved (FDA). 2023: Drug approval — Pegunigalsidase alfa approved (FDA). 2023: Drug approval — Quizartinib approved (FDA). 2023: Drug approval — Donislecel approved (FDA). 2023: Drug approval — Nedosiran sodium approved (FDA). 2023: Drug approval — Prothrombin approved (FDA). 2023: Drug approval — Etranacogene dezaparvovec approved (FDA). 2023: Drug approval — Rozanolixizumab approved (FDA). 2023: Drug approval — Cipaglucosidase alfa approved (FDA). 2023: Drug approval — Lebrikizumab approved (FDA). 2024: Drug approval — Fidanacogene elaparvovec approved (FDA). 2024: Drug approval — Crinecerfont approved (FDA). 2024: Drug approval — Danicopan approved (FDA). 2024: Drug approval — Revumenib approved (FDA). 2024: Drug approval — Obecabtagene autoleucel approved (FDA). 2024: Drug approval — Imetelstat sodium approved (FDA). 2024: Drug approval — Acoramidis approved (FDA). 2024: Drug approval — Insulin icodec approved (FDA). 2024: Drug approval — Levacetylleucine approved (FDA). 2024: Drug approval — Arimoclomol approved (FDA)

Sudden infant death syndrome

Milestones

Related